

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.76167438 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.76167438 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.56410060 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.56410060 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.44768823 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.24948018 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 4.90628430 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 4.90628430 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.90628430 |
| 10 | kynurenine metabolic process (GO:0070189) | 4.89330394 |
| 11 | high-density lipoprotein particle remodeling (GO:0034375) | 4.86821443 |
| 12 | urea cycle (GO:0000050) | 4.76969554 |
| 13 | urea metabolic process (GO:0019627) | 4.76969554 |
| 14 | regulation of triglyceride catabolic process (GO:0010896) | 4.76396879 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.65134506 |
| 16 | intestinal cholesterol absorption (GO:0030299) | 4.63600029 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.60222553 |
| 18 | epoxygenase P450 pathway (GO:0019373) | 4.59701495 |
| 19 | phospholipid efflux (GO:0033700) | 4.55525237 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.54196919 |
| 21 | regulation of cholesterol esterification (GO:0010872) | 4.47915581 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.46522656 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.42968833 |
| 24 | reverse cholesterol transport (GO:0043691) | 4.42085239 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.36415279 |
| 26 | behavioral response to nicotine (GO:0035095) | 4.36123988 |
| 27 | negative regulation of sterol transport (GO:0032372) | 4.33119499 |
| 28 | negative regulation of cholesterol transport (GO:0032375) | 4.33119499 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.31423797 |
| 30 | protein carboxylation (GO:0018214) | 4.31423797 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 4.27885928 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.26432688 |
| 33 | cysteine metabolic process (GO:0006534) | 4.24178760 |
| 34 | complement activation, alternative pathway (GO:0006957) | 4.23985620 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.18807234 |
| 36 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.16266307 |
| 37 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.16266307 |
| 38 | regulation of guanylate cyclase activity (GO:0031282) | 4.14740854 |
| 39 | acylglycerol homeostasis (GO:0055090) | 4.10912490 |
| 40 | triglyceride homeostasis (GO:0070328) | 4.10912490 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.07061601 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.07061601 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.07061601 |
| 44 | drug metabolic process (GO:0017144) | 4.03886076 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.03705060 |
| 46 | homocysteine metabolic process (GO:0050667) | 3.98088302 |
| 47 | regulation of complement activation (GO:0030449) | 3.96547974 |
| 48 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.93942755 |
| 49 | L-fucose catabolic process (GO:0042355) | 3.93734787 |
| 50 | fucose catabolic process (GO:0019317) | 3.93734787 |
| 51 | L-fucose metabolic process (GO:0042354) | 3.93734787 |
| 52 | bile acid metabolic process (GO:0008206) | 3.93245035 |
| 53 | bile acid and bile salt transport (GO:0015721) | 3.91802771 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.91626736 |
| 55 | intestinal absorption (GO:0050892) | 3.89876952 |
| 56 | cholesterol efflux (GO:0033344) | 3.86050024 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 3.85011428 |
| 58 | serine family amino acid catabolic process (GO:0009071) | 3.78479751 |
| 59 | drug catabolic process (GO:0042737) | 3.73292263 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 3.73058726 |
| 61 | cholesterol homeostasis (GO:0042632) | 3.72348098 |
| 62 | flavonoid metabolic process (GO:0009812) | 3.70590928 |
| 63 | phospholipid homeostasis (GO:0055091) | 3.69553340 |
| 64 | alkaloid metabolic process (GO:0009820) | 3.68539719 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 3.68172344 |
| 66 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67160544 |
| 67 | sterol homeostasis (GO:0055092) | 3.67154352 |
| 68 | lysine catabolic process (GO:0006554) | 3.62373009 |
| 69 | lysine metabolic process (GO:0006553) | 3.62373009 |
| 70 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.61051121 |
| 71 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.58550507 |
| 72 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.58550507 |
| 73 | positive regulation of respiratory burst (GO:0060267) | 3.58406693 |
| 74 | cellular glucuronidation (GO:0052695) | 3.58267498 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 3.53407352 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 3.53381993 |
| 77 | arginine metabolic process (GO:0006525) | 3.51684921 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 3.50861510 |
| 79 | tyrosine metabolic process (GO:0006570) | 3.49386353 |
| 80 | sulfate transmembrane transport (GO:1902358) | 3.44165412 |
| 81 | fibrinolysis (GO:0042730) | 3.42932478 |
| 82 | ethanol oxidation (GO:0006069) | 3.42860715 |
| 83 | lipoprotein metabolic process (GO:0042157) | 3.42073291 |
| 84 | phenylpropanoid metabolic process (GO:0009698) | 3.37565896 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.36035845 |
| 86 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.35527362 |
| 87 | indolalkylamine metabolic process (GO:0006586) | 3.35373533 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 3.35306395 |
| 89 | negative regulation of lipase activity (GO:0060192) | 3.32783649 |
| 90 | amine catabolic process (GO:0009310) | 3.30161117 |
| 91 | cellular biogenic amine catabolic process (GO:0042402) | 3.30161117 |
| 92 | quinone biosynthetic process (GO:1901663) | 3.29853838 |
| 93 | cellular ketone body metabolic process (GO:0046950) | 3.28917739 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 3.28886864 |
| 95 | cellular modified amino acid catabolic process (GO:0042219) | 3.26453011 |
| 96 | transcytosis (GO:0045056) | 3.23541495 |
| 97 | glutamate metabolic process (GO:0006536) | 3.22945267 |
| 98 | ethanol metabolic process (GO:0006067) | 3.20612973 |
| 99 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.20364891 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.20082470 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.20082470 |
| 102 | ketone body metabolic process (GO:1902224) | 3.19957781 |
| 103 | acute-phase response (GO:0006953) | 3.19428144 |
| 104 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.16209759 |
| 105 | protein-lipid complex assembly (GO:0065005) | 3.15364846 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.14177801 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.11539020 |
| 108 | angiotensin maturation (GO:0002003) | 3.10900141 |
| 109 | carnitine metabolic process (GO:0009437) | 3.10683432 |
| 110 | auditory receptor cell differentiation (GO:0042491) | 3.09861385 |
| 111 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.09780162 |
| 112 | coenzyme catabolic process (GO:0009109) | 3.09602214 |
| 113 | oxidative demethylation (GO:0070989) | 3.09264579 |
| 114 | drug transmembrane transport (GO:0006855) | 3.06655667 |
| 115 | lipid homeostasis (GO:0055088) | 3.06154144 |
| 116 | vitamin biosynthetic process (GO:0009110) | 3.05102054 |
| 117 | exogenous drug catabolic process (GO:0042738) | 3.03794729 |
| 118 | intestinal epithelial cell development (GO:0060576) | 3.03747805 |
| 119 | arginine catabolic process (GO:0006527) | 3.03727169 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.03333018 |
| 121 | desmosome organization (GO:0002934) | 3.02810355 |
| 122 | low-density lipoprotein particle remodeling (GO:0034374) | 3.02285883 |
| 123 | cholesterol transport (GO:0030301) | 3.02151636 |
| 124 | sterol transport (GO:0015918) | 3.02151636 |
| 125 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.01975287 |
| 126 | primary alcohol catabolic process (GO:0034310) | 3.01721304 |
| 127 | fatty acid oxidation (GO:0019395) | 3.01018958 |
| 128 | glutathione biosynthetic process (GO:0006750) | 3.00436418 |
| 129 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.00423945 |
| 130 | heme transport (GO:0015886) | 2.98798330 |
| 131 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.98162144 |
| 132 | positive regulation of fatty acid oxidation (GO:0046321) | 2.97780535 |
| 133 | fucosylation (GO:0036065) | 2.93478307 |
| 134 | positive regulation of icosanoid secretion (GO:0032305) | 2.91471289 |
| 135 | sulfate transport (GO:0008272) | 2.91287786 |
| 136 | positive regulation of fatty acid transport (GO:2000193) | 2.90594485 |
| 137 | phenol-containing compound catabolic process (GO:0019336) | 2.85859277 |
| 138 | drug transport (GO:0015893) | 2.83608664 |
| 139 | digestion (GO:0007586) | 2.83533459 |
| 140 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.82389236 |
| 141 | quinone metabolic process (GO:1901661) | 2.79382530 |
| 142 | vitamin transport (GO:0051180) | 2.76071980 |
| 143 | sulfur compound transport (GO:0072348) | 2.75489223 |
| 144 | vitamin transmembrane transport (GO:0035461) | 2.75321086 |
| 145 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.75168454 |
| 146 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.75168454 |
| 147 | endocrine process (GO:0050886) | 2.75168454 |
| 148 | nucleoside transmembrane transport (GO:1901642) | 2.73744416 |
| 149 | GDP-mannose metabolic process (GO:0019673) | 2.72895160 |
| 150 | transepithelial transport (GO:0070633) | 2.70313682 |
| 151 | oligosaccharide biosynthetic process (GO:0009312) | 2.68976071 |
| 152 | regulation of cGMP biosynthetic process (GO:0030826) | 2.66812022 |
| 153 | primary alcohol metabolic process (GO:0034308) | 2.65326460 |
| 154 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.64222987 |
| 155 | sulfation (GO:0051923) | 2.62012870 |
| 156 | omega-hydroxylase P450 pathway (GO:0097267) | 2.60148452 |
| 157 | multicellular organismal water homeostasis (GO:0050891) | 2.60027526 |
| 158 | establishment of skin barrier (GO:0061436) | 2.58965058 |
| 159 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.57719175 |
| 160 | renal system process involved in regulation of blood volume (GO:0001977) | 2.54624764 |
| 161 | ATP synthesis coupled proton transport (GO:0015986) | 2.53900098 |
| 162 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.53900098 |
| 163 | iron coordination entity transport (GO:1901678) | 2.49895028 |
| 164 | hormone catabolic process (GO:0042447) | 2.46420898 |
| 165 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.44789228 |
| 166 | xenobiotic metabolic process (GO:0006805) | 2.44231526 |
| 167 | regulation of water loss via skin (GO:0033561) | 2.43401098 |
| 168 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.43202197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.52244336 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.42602312 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.00992903 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.43730926 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.91954503 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.78831451 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.65632833 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.91216322 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.87766673 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.32454776 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.12930284 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.04211657 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.00476342 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.83790878 |
| 15 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.21623945 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.21412185 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.17317400 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88890544 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88491965 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86599185 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.84229954 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.83736821 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.82238655 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76872249 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.74349516 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.73669553 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73056200 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71614310 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67595292 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.66155653 |
| 31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.65959738 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63127116 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59956477 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50550441 |
| 35 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.49845737 |
| 36 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.49845737 |
| 37 | ERA_21632823_ChIP-Seq_H3396_Human | 1.49567284 |
| 38 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.49201606 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48262365 |
| 40 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.48030166 |
| 41 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46652893 |
| 42 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45698042 |
| 43 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.45660559 |
| 44 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43515391 |
| 45 | AR_20517297_ChIP-Seq_VCAP_Human | 1.42999941 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42954186 |
| 47 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.40568115 |
| 48 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.39539309 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38491677 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30675106 |
| 51 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.29777415 |
| 52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29198208 |
| 53 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.27664487 |
| 54 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.25659955 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25617550 |
| 56 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.24957577 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23247930 |
| 58 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22861721 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21781753 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21391298 |
| 61 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.21177366 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20800449 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20532900 |
| 64 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20130087 |
| 65 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18732218 |
| 66 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.18570798 |
| 67 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.18288784 |
| 68 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18018920 |
| 69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17959063 |
| 70 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.16902099 |
| 71 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.16543886 |
| 72 | P300_27268052_Chip-Seq_Bcells_Human | 1.14828009 |
| 73 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.14071603 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13576448 |
| 75 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13047281 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12189667 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12103591 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11665406 |
| 79 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11430007 |
| 80 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11166948 |
| 81 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10516786 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.09897649 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09786934 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09174752 |
| 85 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.07389391 |
| 86 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.07371640 |
| 87 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07328480 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06929631 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06603231 |
| 90 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.05284811 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04951711 |
| 92 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03118993 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01575522 |
| 94 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00862616 |
| 95 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00455470 |
| 96 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00280959 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99767599 |
| 98 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99456131 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99410934 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98968347 |
| 101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98321450 |
| 102 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98321450 |
| 103 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.98223760 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96920826 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95534124 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95225323 |
| 107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95096645 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92626170 |
| 109 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.92244314 |
| 110 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92082403 |
| 111 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.92007523 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89929085 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89448361 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87854116 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87504361 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87088973 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85780568 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83046586 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82903277 |
| 120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81847573 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81571088 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79264288 |
| 123 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78176077 |
| 124 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77555043 |
| 125 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77555043 |
| 126 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77177587 |
| 127 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76570215 |
| 128 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75432126 |
| 129 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.74831335 |
| 130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74734903 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74734903 |
| 132 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.74720849 |
| 133 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74514049 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74290192 |
| 135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.73001637 |
| 136 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72888437 |
| 137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72159896 |
| 138 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.71430830 |
| 139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.71012966 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69530728 |
| 141 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68314616 |
| 142 | ATF3_27146783_Chip-Seq_COLON_Human | 0.67670569 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.64915544 |
| 144 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.64251326 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.63889607 |
| 146 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62929367 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61817687 |
| 148 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.61355197 |
| 149 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.61275060 |
| 150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61141978 |
| 151 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.59804811 |
| 152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.59259755 |
| 153 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59139536 |
| 154 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.57259509 |
| 155 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.56935250 |
| 156 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56178962 |
| 157 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.55519552 |
| 158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55352144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.71477645 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.97629963 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.18759304 |
| 4 | MP0005365_abnormal_bile_salt | 4.53390946 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.93257372 |
| 6 | MP0002254_reproductive_system_inflammat | 3.67049575 |
| 7 | MP0003252_abnormal_bile_duct | 3.34414702 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.18670883 |
| 9 | MP0009840_abnormal_foam_cell | 2.99366491 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.94935544 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.88131784 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.81792309 |
| 13 | MP0005083_abnormal_biliary_tract | 2.74310258 |
| 14 | MP0004043_abnormal_pH_regulation | 2.66359055 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.59597090 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.54564442 |
| 17 | MP0000566_synostosis | 2.46923703 |
| 18 | MP0004147_increased_porphyrin_level | 2.39798098 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.10759932 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.02899119 |
| 21 | MP0005332_abnormal_amino_acid | 2.01559213 |
| 22 | MP0008872_abnormal_physiological_respon | 1.95166573 |
| 23 | MP0002796_impaired_skin_barrier | 1.92700753 |
| 24 | MP0000609_abnormal_liver_physiology | 1.78729552 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.72632202 |
| 26 | MP0003195_calcinosis | 1.72230659 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.69354760 |
| 28 | MP0000427_abnormal_hair_cycle | 1.65224997 |
| 29 | MP0001664_abnormal_digestion | 1.53064415 |
| 30 | MP0001485_abnormal_pinna_reflex | 1.51957825 |
| 31 | MP0001765_abnormal_ion_homeostasis | 1.48017238 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.45876095 |
| 33 | MP0004885_abnormal_endolymph | 1.43796840 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.42088383 |
| 35 | MP0005451_abnormal_body_composition | 1.41116119 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.37656639 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.37276946 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.31221038 |
| 39 | MP0001346_abnormal_lacrimal_gland | 1.29110753 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.27315041 |
| 41 | MP0003878_abnormal_ear_physiology | 1.27315041 |
| 42 | MP0003868_abnormal_feces_composition | 1.26402981 |
| 43 | MP0002938_white_spotting | 1.26201677 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.25891275 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.23090668 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.22708362 |
| 47 | MP0004133_heterotaxia | 1.18634177 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.17722474 |
| 49 | MP0003283_abnormal_digestive_organ | 1.16525488 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.14400483 |
| 51 | MP0009764_decreased_sensitivity_to | 1.14267231 |
| 52 | MP0001764_abnormal_homeostasis | 1.11697343 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.11174919 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10662474 |
| 55 | MP0001663_abnormal_digestive_system | 1.10333171 |
| 56 | MP0005647_abnormal_sex_gland | 1.09705617 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.06748504 |
| 58 | MP0003315_abnormal_perineum_morphology | 1.05509035 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.04922899 |
| 60 | MP0001873_stomach_inflammation | 1.04170082 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.03299912 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.02712802 |
| 63 | MP0003866_abnormal_defecation | 1.02577717 |
| 64 | MP0003718_maternal_effect | 1.02416190 |
| 65 | MP0002060_abnormal_skin_morphology | 1.01810769 |
| 66 | MP0001881_abnormal_mammary_gland | 1.01262256 |
| 67 | MP0003879_abnormal_hair_cell | 0.99971288 |
| 68 | MP0005501_abnormal_skin_physiology | 0.99492601 |
| 69 | MP0002234_abnormal_pharynx_morphology | 0.98602897 |
| 70 | MP0002098_abnormal_vibrissa_morphology | 0.97141345 |
| 71 | MP0000579_abnormal_nail_morphology | 0.95673377 |
| 72 | MP0000685_abnormal_immune_system | 0.95625250 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 0.95207708 |
| 74 | MP0000647_abnormal_sebaceous_gland | 0.94550724 |
| 75 | MP0003300_gastrointestinal_ulcer | 0.94464029 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 0.93590430 |
| 77 | MP0001216_abnormal_epidermal_layer | 0.93226664 |
| 78 | MP0002822_catalepsy | 0.93104607 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 0.92511150 |
| 80 | MP0009697_abnormal_copulation | 0.91597477 |
| 81 | MP0003186_abnormal_redox_activity | 0.90331131 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.90162693 |
| 83 | MP0003724_increased_susceptibility_to | 0.89247153 |
| 84 | MP0004947_skin_inflammation | 0.88946771 |
| 85 | MP0003011_delayed_dark_adaptation | 0.88668119 |
| 86 | MP0002736_abnormal_nociception_after | 0.87507187 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 0.87065733 |
| 88 | MP0000598_abnormal_liver_morphology | 0.86930876 |
| 89 | MP0000470_abnormal_stomach_morphology | 0.86391234 |
| 90 | MP0008469_abnormal_protein_level | 0.85152530 |
| 91 | MP0001188_hyperpigmentation | 0.85028206 |
| 92 | MP0000462_abnormal_digestive_system | 0.84622256 |
| 93 | MP0000026_abnormal_inner_ear | 0.84132224 |
| 94 | MP0010155_abnormal_intestine_physiology | 0.83622635 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.83333160 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.83297237 |
| 97 | MP0009763_increased_sensitivity_to | 0.81976816 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.80814047 |
| 99 | MP0000537_abnormal_urethra_morphology | 0.79145118 |
| 100 | MP0005670_abnormal_white_adipose | 0.79020637 |
| 101 | MP0005408_hypopigmentation | 0.77773061 |
| 102 | MP0004742_abnormal_vestibular_system | 0.77375223 |
| 103 | MP0000230_abnormal_systemic_arterial | 0.77314358 |
| 104 | MP0004381_abnormal_hair_follicle | 0.75486870 |
| 105 | MP0001853_heart_inflammation | 0.75442290 |
| 106 | MP0003953_abnormal_hormone_level | 0.75066826 |
| 107 | MP0001919_abnormal_reproductive_system | 0.74094098 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.72880368 |
| 109 | MP0000762_abnormal_tongue_morphology | 0.72645838 |
| 110 | MP0009785_altered_susceptibility_to | 0.71978965 |
| 111 | MP0001756_abnormal_urination | 0.71722502 |
| 112 | MP0002971_abnormal_brown_adipose | 0.71022749 |
| 113 | MP0002160_abnormal_reproductive_system | 0.70885261 |
| 114 | MP0002282_abnormal_trachea_morphology | 0.70711480 |
| 115 | MP0005275_abnormal_skin_tensile | 0.70024478 |
| 116 | MP0003119_abnormal_digestive_system | 0.69956527 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.69511536 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.69509097 |
| 119 | MP0001968_abnormal_touch/_nociception | 0.68574441 |
| 120 | MP0003436_decreased_susceptibility_to | 0.67845990 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.67355789 |
| 122 | MP0009642_abnormal_blood_homeostasis | 0.67112308 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.65656997 |
| 124 | MP0001905_abnormal_dopamine_level | 0.64638517 |
| 125 | MP0000538_abnormal_urinary_bladder | 0.64619272 |
| 126 | MP0010771_integument_phenotype | 0.64299618 |
| 127 | MP0001348_abnormal_lacrimal_gland | 0.64230099 |
| 128 | MP0010386_abnormal_urinary_bladder | 0.63718985 |
| 129 | MP0001501_abnormal_sleep_pattern | 0.63671085 |
| 130 | MP0008789_abnormal_olfactory_epithelium | 0.63470432 |
| 131 | MP0000516_abnormal_urinary_system | 0.63419100 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.63419100 |
| 133 | MP0000377_abnormal_hair_follicle | 0.63277481 |
| 134 | MP0005389_reproductive_system_phenotype | 0.63250077 |
| 135 | MP0009053_abnormal_anal_canal | 0.63233237 |
| 136 | MP0000604_amyloidosis | 0.63218060 |
| 137 | MP0005220_abnormal_exocrine_pancreas | 0.61458403 |
| 138 | MP0000467_abnormal_esophagus_morphology | 0.60918541 |
| 139 | MP0005376_homeostasis/metabolism_phenot | 0.60534079 |
| 140 | MP0001835_abnormal_antigen_presentation | 0.60037159 |
| 141 | MP0002009_preneoplasia | 0.58790033 |
| 142 | MP0005266_abnormal_metabolism | 0.58005555 |
| 143 | MP0004272_abnormal_basement_membrane | 0.57869387 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.57363446 |
| 145 | MP0004130_abnormal_muscle_cell | 0.56672024 |
| 146 | MP0005334_abnormal_fat_pad | 0.55857831 |
| 147 | MP0005448_abnormal_energy_balance | 0.55180675 |
| 148 | MP0000383_abnormal_hair_follicle | 0.53819233 |
| 149 | MP0005666_abnormal_adipose_tissue | 0.53678275 |
| 150 | MP0008004_abnormal_stomach_pH | 0.53549802 |
| 151 | MP0009384_cardiac_valve_regurgitation | 0.53306242 |
| 152 | MP0001845_abnormal_inflammatory_respons | 0.53125187 |
| 153 | MP0000249_abnormal_blood_vessel | 0.52941252 |
| 154 | MP0005023_abnormal_wound_healing | 0.52749124 |
| 155 | MP0003656_abnormal_erythrocyte_physiolo | 0.52475224 |
| 156 | MP0001191_abnormal_skin_condition | 0.52090760 |
| 157 | MP0009931_abnormal_skin_appearance | 0.51170785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.10445424 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.85665824 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.64484679 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.50179208 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.40005689 |
| 6 | Xanthomatosis (HP:0000991) | 5.24538811 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.04341711 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.66467505 |
| 9 | Decreased circulating renin level (HP:0003351) | 4.30906956 |
| 10 | Complement deficiency (HP:0004431) | 4.21106754 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.19195178 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 4.16678019 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.16316691 |
| 14 | Epidermoid cyst (HP:0200040) | 4.01863124 |
| 15 | Fat malabsorption (HP:0002630) | 3.93856274 |
| 16 | Hyperammonemia (HP:0001987) | 3.91789693 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.79032482 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.76980361 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.71272919 |
| 20 | Joint hemorrhage (HP:0005261) | 3.68665382 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.64646205 |
| 22 | Hyperglycinuria (HP:0003108) | 3.61187629 |
| 23 | Hyperactive renin-angiotensin system (HP:0000841) | 3.54131644 |
| 24 | Ketosis (HP:0001946) | 3.50302117 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.46795168 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.40159688 |
| 27 | Abnormality of renin-angiotensin system (HP:0000847) | 3.36497565 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34151573 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.33772530 |
| 30 | Hydroxyprolinuria (HP:0003080) | 3.28027882 |
| 31 | Abnormality of proline metabolism (HP:0010907) | 3.28027882 |
| 32 | Esophageal varix (HP:0002040) | 3.27551493 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.27185245 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.27185245 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24615861 |
| 36 | Abnormality of complement system (HP:0005339) | 3.22443669 |
| 37 | Hyperglycinemia (HP:0002154) | 3.19580245 |
| 38 | Alkalosis (HP:0001948) | 3.19156089 |
| 39 | Vascular calcification (HP:0004934) | 3.03964618 |
| 40 | Myocardial infarction (HP:0001658) | 3.01100427 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.98305769 |
| 42 | Congenital sensorineural hearing impairment (HP:0008527) | 2.97984300 |
| 43 | Spontaneous abortion (HP:0005268) | 2.93897539 |
| 44 | Malnutrition (HP:0004395) | 2.90759764 |
| 45 | Glycosuria (HP:0003076) | 2.89578875 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 2.89578875 |
| 47 | Steatorrhea (HP:0002570) | 2.88810988 |
| 48 | Hyperalaninemia (HP:0003348) | 2.88698001 |
| 49 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.88698001 |
| 50 | Abnormality of alanine metabolism (HP:0010916) | 2.88698001 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 2.86353380 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.84574641 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83668457 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.81856090 |
| 55 | Metabolic alkalosis (HP:0200114) | 2.81266436 |
| 56 | Pancreatic cysts (HP:0001737) | 2.71956887 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.71949584 |
| 58 | Cardiovascular calcification (HP:0011915) | 2.69826867 |
| 59 | Ketoacidosis (HP:0001993) | 2.69065634 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 2.65852494 |
| 61 | Molar tooth sign on MRI (HP:0002419) | 2.65852494 |
| 62 | Amyloidosis (HP:0011034) | 2.55292127 |
| 63 | Congenital stationary night blindness (HP:0007642) | 2.54336406 |
| 64 | Hyperbilirubinemia (HP:0002904) | 2.51957265 |
| 65 | True hermaphroditism (HP:0010459) | 2.50139257 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.47184795 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 2.41462997 |
| 68 | Abnormal hair laboratory examination (HP:0003328) | 2.40037484 |
| 69 | Hemorrhage of the eye (HP:0011885) | 2.39882810 |
| 70 | Tubular atrophy (HP:0000092) | 2.38993922 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.38535851 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.38535851 |
| 73 | Metabolic acidosis (HP:0001942) | 2.38170457 |
| 74 | Congenital, generalized hypertrichosis (HP:0004540) | 2.38118466 |
| 75 | Abnormality of vitamin B metabolism (HP:0004340) | 2.36664049 |
| 76 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.36438474 |
| 77 | Pili torti (HP:0003777) | 2.35926570 |
| 78 | Amelogenesis imperfecta (HP:0000705) | 2.35892998 |
| 79 | Gout (HP:0001997) | 2.34265940 |
| 80 | Abnormality of the renal cortex (HP:0011035) | 2.31325969 |
| 81 | Acanthocytosis (HP:0001927) | 2.30393800 |
| 82 | Concave nail (HP:0001598) | 2.29116890 |
| 83 | Pancreatic fibrosis (HP:0100732) | 2.28958211 |
| 84 | Delayed CNS myelination (HP:0002188) | 2.28609354 |
| 85 | Onycholysis (HP:0001806) | 2.26187823 |
| 86 | Polycythemia (HP:0001901) | 2.25936036 |
| 87 | Pancreatitis (HP:0001733) | 2.25417776 |
| 88 | Plantar hyperkeratosis (HP:0007556) | 2.24039634 |
| 89 | Skin nodule (HP:0200036) | 2.23269074 |
| 90 | Cholelithiasis (HP:0001081) | 2.22996066 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.21624497 |
| 92 | Confusion (HP:0001289) | 2.21555438 |
| 93 | Ileus (HP:0002595) | 2.21328098 |
| 94 | Hyperphosphaturia (HP:0003109) | 2.18725263 |
| 95 | Abnormality of vitamin metabolism (HP:0100508) | 2.17636490 |
| 96 | Pendular nystagmus (HP:0012043) | 2.17543184 |
| 97 | Type II lissencephaly (HP:0007260) | 2.14690874 |
| 98 | Acute encephalopathy (HP:0006846) | 2.12119263 |
| 99 | Lethargy (HP:0001254) | 2.10779877 |
| 100 | Hyperaldosteronism (HP:0000859) | 2.10517190 |
| 101 | Hypoglycemic seizures (HP:0002173) | 2.09400692 |
| 102 | Cystic liver disease (HP:0006706) | 2.07122656 |
| 103 | Proximal tubulopathy (HP:0000114) | 2.06619965 |
| 104 | Fragile nails (HP:0001808) | 2.05954541 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 2.05704324 |
| 106 | Nephronophthisis (HP:0000090) | 2.05361671 |
| 107 | Furrowed tongue (HP:0000221) | 2.04545879 |
| 108 | Abnormality of magnesium homeostasis (HP:0004921) | 2.04513190 |
| 109 | Chronic hepatic failure (HP:0100626) | 2.03684181 |
| 110 | Gingival bleeding (HP:0000225) | 2.02986457 |
| 111 | Rickets (HP:0002748) | 2.01226599 |
| 112 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.01089718 |
| 113 | Nephritis (HP:0000123) | 1.99946175 |
| 114 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.99050537 |
| 115 | Thrombophlebitis (HP:0004418) | 1.97891900 |
| 116 | Abnormal urine phosphate concentration (HP:0012599) | 1.97443891 |
| 117 | Cerebral palsy (HP:0100021) | 1.96518448 |
| 118 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95958921 |
| 119 | Hypoplasia of the uterus (HP:0000013) | 1.95942255 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95316504 |
| 121 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.92841129 |
| 122 | Late onset (HP:0003584) | 1.92255207 |
| 123 | Hepatic necrosis (HP:0002605) | 1.91792107 |
| 124 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91200182 |
| 125 | Pigmentary retinal degeneration (HP:0001146) | 1.91020715 |
| 126 | Large for gestational age (HP:0001520) | 1.90966304 |
| 127 | Glomerulonephritis (HP:0000099) | 1.88143969 |
| 128 | Abnormality of serum amino acid levels (HP:0003112) | 1.86866686 |
| 129 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.86219145 |
| 130 | Microretrognathia (HP:0000308) | 1.85379876 |
| 131 | Ventricular tachycardia (HP:0004756) | 1.85365581 |
| 132 | Abnormality of chloride homeostasis (HP:0011422) | 1.85220296 |
| 133 | Alopecia of scalp (HP:0002293) | 1.84827386 |
| 134 | Generalized aminoaciduria (HP:0002909) | 1.84467159 |
| 135 | Abnormality of the renal medulla (HP:0100957) | 1.84313795 |
| 136 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84122200 |
| 137 | Spastic diplegia (HP:0001264) | 1.84055031 |
| 138 | Hypokalemia (HP:0002900) | 1.83735528 |
| 139 | Hyperglycemia (HP:0003074) | 1.83601626 |
| 140 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.83407615 |
| 141 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.83407615 |
| 142 | Widely patent fontanelles and sutures (HP:0004492) | 1.83270653 |
| 143 | Chorioretinal atrophy (HP:0000533) | 1.82773477 |
| 144 | Hyperuricemia (HP:0002149) | 1.80908638 |
| 145 | Increased purine levels (HP:0004368) | 1.80908638 |
| 146 | Cerebral edema (HP:0002181) | 1.79757250 |
| 147 | Neonatal onset (HP:0003623) | 1.79491046 |
| 148 | Abnormality of renal excretion (HP:0011036) | 1.78103282 |
| 149 | Abnormality of the gallbladder (HP:0005264) | 1.78050896 |
| 150 | Hypochromic microcytic anemia (HP:0004840) | 1.78046316 |
| 151 | Abnormality of iron homeostasis (HP:0011031) | 1.77958989 |
| 152 | Menorrhagia (HP:0000132) | 1.77680792 |
| 153 | Woolly hair (HP:0002224) | 1.77590242 |
| 154 | Palmoplantar hyperkeratosis (HP:0000972) | 1.77434866 |
| 155 | Vomiting (HP:0002013) | 1.77125428 |
| 156 | Symptomatic seizures (HP:0011145) | 1.76940640 |
| 157 | Hypertriglyceridemia (HP:0002155) | 1.76558859 |
| 158 | Stroke (HP:0001297) | 1.75779221 |
| 159 | Nephrolithiasis (HP:0000787) | 1.75772157 |
| 160 | Palmar hyperkeratosis (HP:0010765) | 1.75615113 |
| 161 | Abnormal drinking behavior (HP:0030082) | 1.75600171 |
| 162 | Polydipsia (HP:0001959) | 1.75600171 |
| 163 | Mitochondrial inheritance (HP:0001427) | 1.74239176 |
| 164 | Abnormal cartilage morphology (HP:0002763) | 1.74233243 |
| 165 | Chronic bronchitis (HP:0004469) | 1.73667125 |
| 166 | Acute necrotizing encephalopathy (HP:0006965) | 1.72580840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 3.87194579 |
| 2 | BCKDK | 3.85981039 |
| 3 | ERN1 | 3.76757218 |
| 4 | MST1R | 3.51008332 |
| 5 | WNK4 | 3.20942955 |
| 6 | FGFR4 | 3.20358237 |
| 7 | FRK | 2.98826106 |
| 8 | MAP3K14 | 2.68941231 |
| 9 | SIK1 | 2.64680615 |
| 10 | STK39 | 2.64571089 |
| 11 | ADRBK2 | 2.55305666 |
| 12 | KDR | 2.38263725 |
| 13 | EPHA2 | 2.30547071 |
| 14 | TIE1 | 2.22977721 |
| 15 | TLK1 | 2.21902019 |
| 16 | MAP3K3 | 2.08582926 |
| 17 | MUSK | 2.07399781 |
| 18 | BMPR1B | 2.01556920 |
| 19 | TYK2 | 2.01093922 |
| 20 | MST4 | 2.00820529 |
| 21 | OXSR1 | 1.98171412 |
| 22 | RIPK1 | 1.85265584 |
| 23 | EPHB1 | 1.83264635 |
| 24 | MAP3K12 | 1.75380078 |
| 25 | VRK2 | 1.73516913 |
| 26 | INSRR | 1.70513307 |
| 27 | CASK | 1.68630623 |
| 28 | MAP4K2 | 1.63491129 |
| 29 | NME1 | 1.62283549 |
| 30 | TBK1 | 1.60151205 |
| 31 | LATS1 | 1.58299854 |
| 32 | EPHB2 | 1.57899959 |
| 33 | MAP2K2 | 1.54930280 |
| 34 | WNK3 | 1.52953743 |
| 35 | ERBB4 | 1.43865912 |
| 36 | PINK1 | 1.42128507 |
| 37 | MET | 1.41805064 |
| 38 | FER | 1.37482433 |
| 39 | PRKCI | 1.35505681 |
| 40 | PRKAA2 | 1.32203564 |
| 41 | MAP3K7 | 1.32110732 |
| 42 | PIK3CG | 1.31272024 |
| 43 | MAP2K6 | 1.31216240 |
| 44 | TGFBR2 | 1.31010608 |
| 45 | MYLK | 1.30085905 |
| 46 | EPHA3 | 1.27300759 |
| 47 | * PTK6 | 1.25089747 |
| 48 | MAP3K2 | 1.23349744 |
| 49 | TAOK3 | 1.22870285 |
| 50 | ZAK | 1.22374471 |
| 51 | CHUK | 1.20651770 |
| 52 | MAP2K3 | 1.17844297 |
| 53 | NEK9 | 1.13238873 |
| 54 | ADRBK1 | 1.11982109 |
| 55 | PTK2 | 1.11831662 |
| 56 | AKT3 | 1.10626478 |
| 57 | PIM2 | 1.09512962 |
| 58 | MAPKAPK3 | 1.09473392 |
| 59 | TRIB3 | 1.07891394 |
| 60 | JAK1 | 1.06303268 |
| 61 | DYRK1B | 1.06214795 |
| 62 | PKN2 | 1.06150351 |
| 63 | FLT3 | 1.05577370 |
| 64 | IKBKB | 1.03859468 |
| 65 | IKBKE | 1.03519520 |
| 66 | DYRK2 | 1.02850747 |
| 67 | BCR | 1.02790282 |
| 68 | STK16 | 1.00830930 |
| 69 | MAPK11 | 0.99280704 |
| 70 | LMTK2 | 0.99112049 |
| 71 | NUAK1 | 0.97493501 |
| 72 | GRK1 | 0.97378002 |
| 73 | FGFR3 | 0.96677073 |
| 74 | MAPK15 | 0.95870962 |
| 75 | PIK3CA | 0.95365525 |
| 76 | TESK2 | 0.86785780 |
| 77 | MAP3K11 | 0.86613493 |
| 78 | IRAK3 | 0.84583988 |
| 79 | LRRK2 | 0.83058126 |
| 80 | JAK3 | 0.81053398 |
| 81 | MAP3K13 | 0.80548526 |
| 82 | MAP2K7 | 0.80431600 |
| 83 | PAK3 | 0.78709746 |
| 84 | LIMK1 | 0.78232258 |
| 85 | ERBB2 | 0.76516538 |
| 86 | MAPK13 | 0.72224757 |
| 87 | MAP3K1 | 0.71145774 |
| 88 | EPHA4 | 0.70661907 |
| 89 | PRKCE | 0.70021554 |
| 90 | TGFBR1 | 0.69747512 |
| 91 | CSK | 0.68927096 |
| 92 | PRKG2 | 0.68087698 |
| 93 | NLK | 0.66429218 |
| 94 | CSNK1A1 | 0.65631633 |
| 95 | STK10 | 0.64785549 |
| 96 | STK38L | 0.64719216 |
| 97 | TTN | 0.63314790 |
| 98 | GSK3A | 0.63003045 |
| 99 | * JAK2 | 0.62970877 |
| 100 | MAP2K1 | 0.62911788 |
| 101 | TESK1 | 0.62827337 |
| 102 | FGFR2 | 0.62358132 |
| 103 | TNIK | 0.60638577 |
| 104 | CDK6 | 0.60270431 |
| 105 | ABL2 | 0.57698704 |
| 106 | PRKAA1 | 0.57038199 |
| 107 | TXK | 0.56892267 |
| 108 | VRK1 | 0.56390419 |
| 109 | PDK2 | 0.54683309 |
| 110 | ICK | 0.52511692 |
| 111 | MATK | 0.52094550 |
| 112 | GRK6 | 0.50942211 |
| 113 | PRKCA | 0.50527817 |
| 114 | PHKG2 | 0.50382922 |
| 115 | PHKG1 | 0.50382922 |
| 116 | TRIM28 | 0.50128833 |
| 117 | NTRK3 | 0.49428899 |
| 118 | IRAK1 | 0.49367590 |
| 119 | PRKCG | 0.49133794 |
| 120 | MAPKAPK5 | 0.48102729 |
| 121 | DAPK2 | 0.46729284 |
| 122 | BMX | 0.44738870 |
| 123 | TRPM7 | 0.43721240 |
| 124 | PRKACA | 0.42697763 |
| 125 | MAPK12 | 0.42505361 |
| 126 | CAMK2D | 0.42202914 |
| 127 | PRKCZ | 0.40591816 |
| 128 | MAP2K4 | 0.38832917 |
| 129 | RPS6KA5 | 0.38764496 |
| 130 | STK3 | 0.38741442 |
| 131 | PRKACG | 0.38445742 |
| 132 | MAP3K4 | 0.36975259 |
| 133 | ARAF | 0.36777505 |
| 134 | MAPKAPK2 | 0.36110350 |
| 135 | CAMK2G | 0.35692060 |
| 136 | RPS6KB2 | 0.35585838 |
| 137 | PRKCD | 0.35549176 |
| 138 | IGF1R | 0.35450431 |
| 139 | PRKD2 | 0.35260441 |
| 140 | MAP3K10 | 0.33931952 |
| 141 | PRKCQ | 0.33674096 |
| 142 | STK24 | 0.31939150 |
| 143 | BMPR2 | 0.30935413 |
| 144 | RPS6KA6 | 0.30808732 |
| 145 | RPS6KA1 | 0.29385409 |
| 146 | TAF1 | 0.28910744 |
| 147 | EGFR | 0.28686482 |
| 148 | ILK | 0.26424018 |
| 149 | RPS6KA2 | 0.24265816 |
| 150 | CSNK2A1 | 0.17887102 |
| 151 | CSNK1G3 | 0.17433792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.82047416 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.58603381 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17799381 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93095750 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85073037 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67028481 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56346370 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45285554 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28194176 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24589128 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.19987511 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19219084 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18662953 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17022473 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15433986 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.10633893 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.98026160 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.92590382 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92582466 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.92423478 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92061831 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.85240213 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76518262 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.75672002 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68292326 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67305172 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65548895 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.63450363 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.60852414 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59948638 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58608732 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45366723 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42895587 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.42809023 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41871806 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41386048 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41016740 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39524427 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39225302 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37339544 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.32507367 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.30867945 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27561244 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.26883167 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26693326 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23290736 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22253147 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16823884 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08325389 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01951524 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01018616 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96477759 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96312117 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95998671 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95512842 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.95333507 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94659318 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92396059 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92277329 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92026712 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90103543 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86754756 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85388677 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81934945 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80860275 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 0.80703841 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80385925 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71592151 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.70025232 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69639313 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67207469 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66550443 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65285614 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63736501 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.60803399 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60517406 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60328943 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59549856 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.53763431 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46629518 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45213902 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44190070 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.43300051 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41570747 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39813872 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38901283 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36629113 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36019237 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35471970 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.32386954 |
| 91 | Protein export_Homo sapiens_hsa03060 | 0.31874204 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30037702 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.29205593 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29066267 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28551524 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.27045268 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26809109 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.26332168 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26237697 |
| 100 | Nicotine addiction_Homo sapiens_hsa05033 | 0.25224342 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24715984 |
| 102 | Proteasome_Homo sapiens_hsa03050 | 0.23664077 |
| 103 | Insulin secretion_Homo sapiens_hsa04911 | 0.23470619 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20901421 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20697164 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.20660722 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20132578 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.18996320 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.12202683 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.11245432 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.10754598 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.10627431 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09374372 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.08350082 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.07945406 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.07761149 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.07273940 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.06271633 |
| 119 | Allograft rejection_Homo sapiens_hsa05330 | 0.05619442 |
| 120 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.04578856 |
| 121 | Pertussis_Homo sapiens_hsa05133 | 0.04569708 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.02209147 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.01167281 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | -8.1605823 |
| 125 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0087830 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0039117 |

